NOVO.B.DK

237.05

-0.5%↓

GMAB.DK

1,642.5

-0.54%↓

HLUNB.DK

37.38

+0.21%↑

ZEAL.DK

288

+2.45%↑

AMBUB.DK

67.65

-0.88%↓

NOVO.B.DK

237.05

-0.5%↓

GMAB.DK

1,642.5

-0.54%↓

HLUNB.DK

37.38

+0.21%↑

ZEAL.DK

288

+2.45%↑

AMBUB.DK

67.65

-0.88%↓

NOVO.B.DK

237.05

-0.5%↓

GMAB.DK

1,642.5

-0.54%↓

HLUNB.DK

37.38

+0.21%↑

ZEAL.DK

288

+2.45%↑

AMBUB.DK

67.65

-0.88%↓

NOVO.B.DK

237.05

-0.5%↓

GMAB.DK

1,642.5

-0.54%↓

HLUNB.DK

37.38

+0.21%↑

ZEAL.DK

288

+2.45%↑

AMBUB.DK

67.65

-0.88%↓

NOVO.B.DK

237.05

-0.5%↓

GMAB.DK

1,642.5

-0.54%↓

HLUNB.DK

37.38

+0.21%↑

ZEAL.DK

288

+2.45%↑

AMBUB.DK

67.65

-0.88%↓

Search

Coloplast A-S (Class B)

Suletud

426.5 -0.72

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

421.9

Max

430.2

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

25.56

57.833

Aktsiakasum

6.32

Dividenditootlus

5.07

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

5.07%

2.47%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-17B

102B

Eelmine avamishind

427.22

Eelmine sulgemishind

426.5

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. märts 2026, 17:19 UTC

Uudisväärsed sündmused

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

20. märts 2026, 16:56 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

20. märts 2026, 16:56 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

20. märts 2026, 16:45 UTC

Uudisväärsed sündmused

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

20. märts 2026, 16:22 UTC

Uudisväärsed sündmused

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

20. märts 2026, 20:50 UTC

Market Talk
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

20. märts 2026, 20:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

20. märts 2026, 19:55 UTC

Market Talk
Uudisväärsed sündmused

Brent Crude Closes Out Volatile Week Higher -- Market Talk

20. märts 2026, 19:28 UTC

Market Talk
Uudisväärsed sündmused

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

20. märts 2026, 19:28 UTC

Omandamised, ülevõtmised, äriostud

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20. märts 2026, 18:39 UTC

Market Talk

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

20. märts 2026, 18:31 UTC

Omandamised, ülevõtmised, äriostud

Honeywell Announces Pricing of Debt Tender Offers >HON

20. märts 2026, 18:19 UTC

Omandamised, ülevõtmised, äriostud

Why Mayo and Soap No Longer Mix for Unilever -- Update

20. märts 2026, 18:15 UTC

Market Talk

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

20. märts 2026, 17:57 UTC

Market Talk

U.S. Oil Rig Count Inches Up -- Market Talk

20. märts 2026, 17:04 UTC

Uudisväärsed sündmused

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

20. märts 2026, 16:20 UTC

Market Talk
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

20. märts 2026, 16:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

20. märts 2026, 15:40 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

20. märts 2026, 15:30 UTC

Tulu

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

20. märts 2026, 15:26 UTC

Market Talk
Tulu
Uudisväärsed sündmused

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

20. märts 2026, 15:26 UTC

Omandamised, ülevõtmised, äriostud

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

20. märts 2026, 15:25 UTC

Market Talk

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

20. märts 2026, 15:19 UTC

Market Talk
Uudisväärsed sündmused

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

20. märts 2026, 14:58 UTC

Uudisväärsed sündmused

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

20. märts 2026, 14:55 UTC

Market Talk
Uudisväärsed sündmused

Gold Lower as Speculative Pullback Extends -- Market Talk

20. märts 2026, 14:54 UTC

Omandamised, ülevõtmised, äriostud

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20. märts 2026, 14:53 UTC

Omandamised, ülevõtmised, äriostud

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

20. märts 2026, 14:46 UTC

Market Talk

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

20. märts 2026, 14:45 UTC

Market Talk
Uudisväärsed sündmused

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat